| Revenue growth | 109.35% YoY to ₹29.44 Cr |
|---|---|
| Margins | EBITDA margin 21.27%, down 241 bps YoY |
| Demand visibility | Cites healthcare demand; no quantified visibility |
Growth
Revenue up 109.35% YoY to ₹29.44 Cr; EBITDA up 88.03%; PAT up 98.66%. Net worth ₹40.2 Cr vs ₹8.3 Cr.
Outlook
No quantified growth guidance. Plans: leased adjacent premises, machinery, automation, new launches, export registrations.
Risks
EBITDA margin down 241 bps to 21.27%; PAT margin down 86 bps; raw material cost more than doubled YoY.
Investor Presentation filed with BSE, BSE: 544694. Summary written with AI assistance from the document.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹311.00
- Market cap
- ₹225.2 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 44.4×Sector 37.9×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Results Update
Accretion Nutraveda released a half-year media release showing revenue up 109.35% to Rs 29.44 crore. EBITDA rose 88.03% and PAT rose 98.66%.
Accretion Nutraveda H1 FY27 Results: Net Profit ₹4.7 Cr, Up 95.8% YoY
Accretion Nutraveda Ltd reported revenue from operations of ₹29.4 Cr (+108.5% YoY) and net profit of ₹4.7 Cr (+95.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.7 Cr · +95.8% YoY
Accretion Nutraveda Other Announcement
Accretion Nutraveda's quarterly shareholding pattern shows promoters holding 73.48%. The routine filing reports no corporate action or event value.
Accretion Nutraveda Board Meeting Date
Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited announced results of its postal ballot. Shareholders approved special resolutions regarding MOA alteration, borrowing limits, and various loan and guarantee authorizations.
Accretion Nutraveda Other Announcement
Accretion Nutraveda Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory disclosure under SEBI LODR.